[cite web | title = Entrez Gene: CTAG1B cancer/testis antigen 1B| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1485| accessdate = ] ] PBB_Summary
section_title =
summary_text =
References
Further reading
PBB_Further_reading
citations =
*cite journal | author=Scanlan MJ, Gure AO, Jungbluth AA, "et al." |title=Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. |journal=Immunol. Rev. |volume=188 |issue= |pages= 22–32 |year= 2003 |pmid= 12445278 |doi=
*cite journal | author=Chen YT, Scanlan MJ, Sahin U, "et al." |title=A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 5 |pages= 1914–8 |year= 1997 |pmid= 9050879 |doi=
*cite journal | author=Chen YT, Boyer AD, Viars CS, "et al." |title=Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. |journal=Cytogenet. Cell Genet. |volume=79 |issue= 3-4 |pages= 237–40 |year= 1998 |pmid= 9605863 |doi=
*cite journal | author=Lethé B, Lucas S, Michaux L, "et al." |title=LAGE-1, a new gene with tumor specificity. |journal=Int. J. Cancer |volume=76 |issue= 6 |pages= 903–8 |year= 1998 |pmid= 9626360 |doi=
*cite journal | author=Wang RF, Johnston SL, Zeng G, "et al." |title=A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. |journal=J. Immunol. |volume=161 |issue= 7 |pages= 3598–606 |year= 1998 |pmid= 9759882 |doi=
*cite journal | author=De Smet C, Lurquin C, Lethé B, "et al." |title=DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. |journal=Mol. Cell. Biol. |volume=19 |issue= 11 |pages= 7327–35 |year= 1999 |pmid= 10523621 |doi=
*cite journal | author=Schultz-Thater E, Noppen C, Gudat F, "et al." |title=NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. |journal=Br. J. Cancer |volume=83 |issue= 2 |pages= 204–8 |year= 2000 |pmid= 10901371 |doi= 10.1054/bjoc.2000.1251
*cite journal | author=Rimoldi D, Rubio-Godoy V, Dutoit V, "et al." |title=Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. |journal=J. Immunol. |volume=165 |issue= 12 |pages= 7253–61 |year= 2001 |pmid= 11120859 |doi=
*cite journal | author=Simpson JC, Wellenreuther R, Poustka A, "et al." |title=Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. |journal=EMBO Rep. |volume=1 |issue= 3 |pages= 287–92 |year= 2001 |pmid= 11256614 |doi= 10.1093/embo-reports/kvd058
*cite journal | author=Jungbluth AA, Chen YT, Stockert E, "et al." |title=Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. |journal=Int. J. Cancer |volume=92 |issue= 6 |pages= 856–60 |year= 2001 |pmid= 11351307 |doi= 10.1002/ijc.1282
*cite journal | author=Goydos JS, Patel M, Shih W |title=NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. |journal=J. Surg. Res. |volume=98 |issue= 2 |pages= 76–80 |year= 2001 |pmid= 11397121 |doi= 10.1006/jsre.2001.6148
*cite journal | author=Aradhya S, Bardaro T, Galgóczy P, "et al." |title=Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. |journal=Hum. Mol. Genet. |volume=10 |issue= 22 |pages= 2557–67 |year= 2002 |pmid= 11709543 |doi=
*cite journal | author=Zarour HM, Maillere B, Brusic V, "et al." |title=NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. |journal=Cancer Res. |volume=62 |issue= 1 |pages= 213–8 |year= 2002 |pmid= 11782380 |doi=
*cite journal | author=Satie AP, Rajpert-De Meyts E, Spagnoli GC, "et al." |title=The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. |journal=Lab. Invest. |volume=82 |issue= 6 |pages= 775–80 |year= 2002 |pmid= 12065688 |doi=
*cite journal | author=Nagata Y, Ono S, Matsuo M, "et al." |title=Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 16 |pages= 10629–34 |year= 2002 |pmid= 12138174 |doi= 10.1073/pnas.112331099
*cite journal | author=Resnick MB, Sabo E, Kondratev S, "et al." |title=Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas. |journal=Int. J. Cancer |volume=101 |issue= 2 |pages= 190–5 |year= 2002 |pmid= 12209997 |doi= 10.1002/ijc.10585
*cite journal | author=Peng LP, Liu HY, Ran YL, "et al." |title= [Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning] |journal=Ai Zheng |volume=21 |issue= 5 |pages= 469–72 |year= 2003 |pmid= 12452034 |doi=
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Gnjatic S, Atanackovic D, Jäger E, "et al." |title=Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 15 |pages= 8862–7 |year= 2003 |pmid= 12853579 |doi= 10.1073/pnas.1133324100
PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes
